Loading clinical trials...
Loading clinical trials...
Mental health disorders, with a 30% annual prevalence rate, are a leading cause of disability and reduced life expectancy. Despite their impact, patient-reported experience measures (PREMs) and outcom...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Assistance Publique Hopitaux De Marseille
NCT04480918 · Treatment Resistant Depression, Major Depressive Episode, and more
NCT07010614 · Schizophrenia Disorders, Mental Disorder, and more
NCT06641297 · Schizophrenia Disorders
NCT06939088 · Alcohol Use Disorder, Alcohol Abuse/Dependence, and more
NCT06732284 · Major Depression, Sleep Inertia
Assistance Publique Hopitaux de Marseille
Marseille
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions